Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein kinase inhibitors in the treatment of pulmonary fibrosis.

Current medicinal chemistry - 1 Jan 2008

Garneau-Tsodikova Sylvie, Thannickal Victor J

Abstract excerpt

Fibrosis of the lung and other organ systems is an increasing cause of morbidity and mortality worldwide. Effective anti-fibrotic agents for such disorders are currently lacking. Injury to epithelium-lined tissues in mammals is typically associated with a mesenchymal response, including the activation of myofibroblasts. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease that results from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Epithelial Cells
Share to Fibroblasts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Focal Adhesion Protein-Tyrosine Kinases

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins c-akt

Share to Pulmonary Fibrosis

Source

Identifiers

PMID: 18855683
DOI: 10.2174/092986708785908969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein kinase inhibitors in the treatment of pulmonary fibrosis.PMID 18855683Read ↗

Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.Semantic proximity Read ↗

p38 kinase inhibitor approved for idiopathic pulmonary fibrosisSemantic proximity Read ↗

FAK-Related Nonkinase Is a Multifunctional Negative Regulator of Pulmonary FibrosisSemantic proximity Read ↗

Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-β.Semantic proximity Read ↗

Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.Semantic proximity Read ↗

Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype.Semantic proximity Read ↗

The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In VivoSemantic proximity Read ↗

Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblastsSemantic proximity Read ↗

Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.Semantic proximity Read ↗

Advances in Targeting IKK and IKK-Related Kinases for Cancer TherapySemantic proximity Read ↗

Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosisSemantic proximity Read ↗

Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis modelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.